TAMM-HORSFALL GLYCOPROTEIN - INHIBITOR OR PROMOTER OF CALCIUM-OXALATE MONOHYDRATE CRYSTALLIZATION PROCESSES

被引:79
|
作者
HESS, B [1 ]
机构
[1] UNIV HOSP BERNE,MED POLICLIN,CH-3010 BERN,SWITZERLAND
来源
UROLOGICAL RESEARCH | 1992年 / 20卷 / 01期
关键词
NEPHROLITHIASIS; CALCIUM OXALATE; INHIBITORS AND PROMOTERS; TAMM-HORSFALL GLYCOPROTEIN;
D O I
10.1007/BF00294343
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The processes of calcium oxalate monohydrate (COM) crystal nucleation, growth and aggregation (agglomeration) generally have been studied using a wide variety of assay systems/conditions. This paper reviews the apparently conflicting data on the effects of Tamm-Horsfall glycoprotein (THP) on COM crystallization processes in vitro. with the main emphasis on crystal aggregation. According to its well-known physico-chemical properties. THP has a dual role in modifying crystal aggregation: at high pH and low ionic strength (IS). THP is a powerful crystal aggregation inhibitor. Upon lowering pH and raising IS, THP viscosity increases, leading to reduced crystal aggregation inhibition. In the presence of additional calcium ions, some THPs even become strong promoters of crystal aggregation. This phenomenon seems to be more pronounced in THPs isolated from recurrent calcium stone formers whose proteins exhibit an abnormally high tendency of polymerization. Recent studies suggest an inherited molecular abnormality of THP among some severe recurrent calcium stone formers.
引用
收藏
页码:83 / 86
页数:4
相关论文
共 50 条
  • [41] URINARY CITRATE [CIT] AND TAMM-HORSFALL PROTEIN [THP] INTERACT IN STONE FORMER (SF) URINE TO INHIBIT CALCIUM-OXALATE MONOHYDRATE (COM) AGGLOMERATION KINETICS [TM]
    ERWIN, DT
    COKER, O
    VAUGHN, JS
    CARRIERE, BT
    LINDBERG, JS
    HUSSERL, FE
    ALLEN, JM
    FUSELIER, HA
    KOK, DJ
    COLE, FE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 861 - 861
  • [42] TAMM-HORSFALL MUCOPROTEIN REDUCES PROMOTION OF CALCIUM-OXALATE CRYSTAL AGGREGATION INDUCED BY URATE IN HUMAN URINE IN-VITRO
    GROVER, PK
    MARSHALL, VR
    RYALL, RL
    CLINICAL SCIENCE, 1994, 87 (02) : 137 - 142
  • [43] Tamm-Horsfall glycoprotein: Biology and clinical relevance
    Serafini-Cessi, F
    Malagolini, N
    Cavallone, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (04) : 658 - 676
  • [44] TAMM-HORSFALL URINARY GLYCOPROTEIN - SUBUNIT STRUCTURE
    FLETCHER, AP
    NEUBERGER, A
    RATCLIFFE, WA
    BIOCHEMICAL JOURNAL, 1970, 120 (02) : 425 - +
  • [45] TAMM-HORSFALL URINARY GLYCOPROTEIN - CHEMICAL COMPOSITION
    FLETCHER, AP
    NEUBERGER, A
    RATCLIFFE, WA
    BIOCHEMICAL JOURNAL, 1970, 120 (02) : 417 - +
  • [46] MOLECULAR AND IMMUNOCYTOCHEMICAL LOCALIZATION OF TAMM-HORSFALL GLYCOPROTEIN
    PIZZONIA, JH
    MILLS, JW
    ZURLO, J
    FRIEDMAN, PA
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 427 - 427
  • [47] STUDIES ON CALCIUM-OXALATE MONOHYDRATE CRYSTALLIZATION - INFLUENCE OF INHIBITORS
    GRASES, F
    KROUPA, M
    COSTABAUZA, A
    UROLOGICAL RESEARCH, 1994, 22 (01): : 39 - 43
  • [48] Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo, SR
    Chen, DHC
    Kaung, HLC
    Resnick, MI
    Yang, LZ
    JOURNAL OF UROLOGY, 2002, 167 (05): : 2192 - 2197
  • [49] MODULATION OF CALCIUM-OXALATE MONOHYDRATE CRYSTALLIZATION KINETICS INVITRO
    KOK, DJ
    PAPAPOULOS, SE
    BLOMEN, LJMJ
    BIJVOET, OLM
    KIDNEY INTERNATIONAL, 1988, 34 (03) : 346 - 350
  • [50] MODULATION OF CALCIUM-OXALATE MONOHYDRATE CRYSTALLIZATION KINETICS INVITRO
    KOK, DJ
    PAPAPOULOS, SE
    QUE, I
    BIJVOET, OLM
    UROLOGICAL RESEARCH, 1988, 16 (03): : 228 - 228